1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Key Pharma News 07 SEPTEMBER 2015

Key Pharma News 07 SEPTEMBER 2015

  • September 2015
  • -
  • Espicom Business Intelligence
  • -
  • 37 pages

Industry Trend Analysis - Intensifying Early Access Climate Requires Companies To Be Proactive
Industry Trend Analysis - Current Ultra-Orphan Disease Investment Will Secure Long-Term Revenue Streams
Industry Trend Analysis - Autoimmune Success Will Be Key To Reversing Arzerra's Fortunes
Industry Trend Analysis - Incyte Faces Difficulty In Breaking Checkpoint Inhibitor Market
Industry Trend Analysis - Pfizer/Hospira Merger Lays Groundwork For Expansion
Industry Brief - Court Rules In Favour Of Lilly In Alimta Patent Challenge
Industry Trend Analysis - Mylan's Acquisition Of Perrigo Still Likely Despite Hardening Attitudes
Industry Trend Analysis - Russia Will Continue To Challenge STADA's Sales Growth
Industry Trend Analysis - Product Refocus Will Be Necessary To Stem Lundbeck's Losses
Industry Trend Analysis - FTC Action Will Serve As A Warning To Other Firms
Industry Trend Analysis - Uptick In Sales Will Strengthen Perrigo's Hand Against Mylan
Industry Trend Analysis - Mylan's European Generic Sales On Course To Dominate In FY16
Industry Brief - Celgene Completes Receptos Acquisition
Industry Trend Analysis - Tesaro's First Drug Faces Battle For Position In Congested CINV Market
Industry Brief - FDA Approves Paediatric Indication For Emend
Industry Brief - FDA Accepts sBLA For Opdivo In Previously Treated Non-Squamous NSCLC
Industry Brief - FDA Accepts Empliciti For Priority Review
Industry Brief - Tafinlar+Mekinist Gains EU Approval For Advanced Melanoma
Industry Brief - Amgen's Repatha Gains FDA Approval
Industry Trend Analysis - Heightened Market Activity Will Dampen Late BRAF/MEK Entry Performance
Industry Brief - FDA Approves Synjardy For Type II Diabetes
Industry Brief - Daiichi Sankyo Gains Supplementary Indication For Artist Tablets In Japan
Industry Brief - FDA Approves First PCSK9 Inhibitor
Industry Trend Analysis - Limited Options Create Favourable Market Environment For Novartis' Odomzo
Industry Brief - Adcetris Receives Regular FDA Approval For Classical HL Following HSCT
Industry Trend Analysis - Changes To Biologic Naming Conventions Gain Air Of Inevitability
Industry Trend Analysis - Patent Victory Will Stabilise Opana ER Sales
Industry Brief - Health Canada Approves Strensiq For Paediatric-Onset HPP
Industry Brief - CellCept Powder For Oral Suspension Approved In Japan
Industry Brief - Companies Gains US Aripiprazole Approval
Industry Trend Analysis - Velcade Successor Will Face Tougher Market Environment
Industry Trend Analysis - Vigilance Key To Realising Addyi's Full Market Potential
Industry Brief - USPTO Institutes Glatiramer Patents Inter Partes Review
Industry Trend Analysis - Zecuity's Launch Will Help Recover Revenues Lost To Generic Copaxone
Industry Trend Analysis - Probuphine Represents A Unique Solution To Opioid Addiction
Industry Brief - Teva Launches Solifenacin In Canada
Industry Brief - First Patient Treated In SAGE-547 Phase III Trial In SRSE
Industry Brief - FDA Grants Breakthrough Therapy Designation To Exelixis' Cabozantinib For Advanced RCC
Industry Trend Analysis - Intarcia's Delivery System Will Secure GLP-1 Market Success
Industry Brief - Jardiance Shows Superiority Over SoC In CV Risk Reduction In Type II Diabetes
Industry Trend Analysis - Combination Approach To Extend Commercial Life Of Volibris/Adcirca

Table Of Contents

Key Pharma News 07 SEPTEMBER 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.